Role of biomarkers in early infectious complications after lung transplantation.
Infections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.Multicentre prospective observational study that incl...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5509107?pdf=render |
id |
doaj-fe647cd0c26b4871ae5bd574ba9f2655 |
---|---|
record_format |
Article |
spelling |
doaj-fe647cd0c26b4871ae5bd574ba9f26552020-11-25T01:20:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018020210.1371/journal.pone.0180202Role of biomarkers in early infectious complications after lung transplantation.Borja SuberviolaLuzdivina RellanJordi RieraReyes IranzoAscension Garcia CamposJuan Carlos RoblesRosario VicenteEduardo MiñambresMiguel SantibanezInfections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.Multicentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days.We included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively).In the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period.http://europepmc.org/articles/PMC5509107?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Borja Suberviola Luzdivina Rellan Jordi Riera Reyes Iranzo Ascension Garcia Campos Juan Carlos Robles Rosario Vicente Eduardo Miñambres Miguel Santibanez |
spellingShingle |
Borja Suberviola Luzdivina Rellan Jordi Riera Reyes Iranzo Ascension Garcia Campos Juan Carlos Robles Rosario Vicente Eduardo Miñambres Miguel Santibanez Role of biomarkers in early infectious complications after lung transplantation. PLoS ONE |
author_facet |
Borja Suberviola Luzdivina Rellan Jordi Riera Reyes Iranzo Ascension Garcia Campos Juan Carlos Robles Rosario Vicente Eduardo Miñambres Miguel Santibanez |
author_sort |
Borja Suberviola |
title |
Role of biomarkers in early infectious complications after lung transplantation. |
title_short |
Role of biomarkers in early infectious complications after lung transplantation. |
title_full |
Role of biomarkers in early infectious complications after lung transplantation. |
title_fullStr |
Role of biomarkers in early infectious complications after lung transplantation. |
title_full_unstemmed |
Role of biomarkers in early infectious complications after lung transplantation. |
title_sort |
role of biomarkers in early infectious complications after lung transplantation. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Infections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.Multicentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days.We included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively).In the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period. |
url |
http://europepmc.org/articles/PMC5509107?pdf=render |
work_keys_str_mv |
AT borjasuberviola roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT luzdivinarellan roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT jordiriera roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT reyesiranzo roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT ascensiongarciacampos roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT juancarlosrobles roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT rosariovicente roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT eduardominambres roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation AT miguelsantibanez roleofbiomarkersinearlyinfectiouscomplicationsafterlungtransplantation |
_version_ |
1725135200459948032 |